CardiologyOnline.net

Cardiology Xagena

Search results for "Clopidogrel"

Patients whose occluded arteries were treated with standard fibrinolytic regimen, including Acetylsalicylic acid ( Aspirin ), following acute myocardial infarction with ST-segment elevation ( STEMI ) ...


Study treatments for the ACTIVE W trial of the ACTIVE ( Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events ) program have been discontinued due to a significant di ...


Aspirin and Clopidogrel ( Plavix ) are platelet antiaggregant drugs widely used and proven to be effective in the treatment of an acute coronary syndrome ( ACS ). High-risk patients with non-ST segme ...


A review of more than 56,000 cases of acute coronary syndromes reveals that older patients are less likely to receive treatment recommended by guidelines, even though they benefit as much or more than ...


Results from three early-phase, cross-over studies demonstrated that all subjects responded to Prasugrel ( Effient ), an investigational antiplatelet agent, while 22 to 43 percent of the same subjects ...


Researchers from Northwestern Memorial Hospital have found that in some patients, the stents can cause allergic reactions that can have serious consequences. The findings have been published in the ...


Patients with myocardial infarction who stopped taking antiplatelet drugs within 30 days of receiving a drug-coated stent had nine times the risk of death compared to patients who followed doctors' or ...


The American College of Cardiology ( ACC ) and the American Heart Association ( AHA ) have jointly released revised Guidelines for the Management of Patients with Unstable Angina and Non-ST-Elevation ...


Results from the CHARISMA ( Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance ) trial showed an excess mortality in patients randomized to Clopidogrel ( P ...


There are conflicting data regarding whether statins predominantly metabolized by CYP3A4 reduce the metabolism of Clopidogrel ( Plavix ) to its active metabolite and diminish its clinical efficacy. ...


The adjunctive use of Celecoxib ( Celebrex ) for 6 months after stent implantation in patients with coronary artery disease is safe and can reduce the need for revascularisation of the target lesion. ...


Patients who receive the anti-platelet medication Clopidogrel ( Plavix ) following an acute coronary syndrome appear to be at greater risk of a heart attack or death in the first 90 days after stoppin ...


Prasugrel ( Efient, Effient ), a new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic event ...


Prasugrel ( Efient, Effient ), a new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic eve ...


In patients with myocardial infarction, risk of hospital admission for bleeding increases with the number of antithrombotic drugs used. Patients with non-fatal bleeding are also much more likely to su ...